FNWFX
Price
$80.67
Change
-$1.85 (-2.24%)
Updated
Dec 18 closing price
NEMRX
Price
$19.47
Change
-$0.32 (-1.62%)
Updated
Dec 18 closing price
Ad is loading...

FNWFX vs NEMRX

Header iconFNWFX vs NEMRX Comparison
Open Charts FNWFX vs NEMRXBanner chart's image
American Funds New World F3
Price$80.67
Change-$1.85 (-2.24%)
VolumeN/A
CapitalizationN/A
Neuberger Berman Emerg Mkts Eq R3
Price$19.47
Change-$0.32 (-1.62%)
VolumeN/A
CapitalizationN/A
FNWFX vs NEMRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FNWFX vs. NEMRX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNWFX is a Buy and NEMRX is a Hold.

FUNDAMENTALS
Fundamentals
FNWFX has more cash in the bank: 64B vs. NEMRX (194M). FNWFX pays higher dividends than NEMRX: FNWFX (1.56) vs NEMRX (0.86). FNWFX was incepted earlier than NEMRX: FNWFX (8 years) vs NEMRX (15 years). NEMRX is a more actively managed with annual turnover of: 58.00 vs. FNWFX (32.00). NEMRX has a lower initial minimum investment than FNWFX: NEMRX (0) vs FNWFX (1000000). NEMRX annual gain was more profitable for investors over the last year : 16.34 vs. FNWFX (12.00). FNWFX return over 5 years is better than : 16.03 vs. NEMRX (-2.28).
FNWFXNEMRXFNWFX / NEMRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years15 years-
Gain YTD10.02714.06371%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets64B194M32,990%
Annual Yield % from dividends1.560.86181%
Returns for 1 year12.0016.3473%
Returns for 3 years0.71-8.51-8%
Returns for 5 years16.03-2.28-702%
Returns for 10 yearsN/A27.20-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRC75.93-0.76
-0.99%
Brady Corp
GEN29.38-0.35
-1.18%
Gen Digital
SACH1.24-0.03
-2.36%
Sachem Capital Corp
NN17.55-0.45
-2.50%
NextNav
CANF1.42-0.09
-5.96%
Can-Fite BioPharma Ltd